| Kelli Henning, | |
|
323 Highway 64 E, Alma, AR 72921-3318 | |
| (479) 632-9080 | |
| Not Available |
| Full Name | Kelli Henning |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 323 Highway 64 E, Alma, Arkansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033637962 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | PD08331 (Arkansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Kelli Henning, 323 Highway 64 E, Alma, AR 72921-3318 Ph: (479) 632-9080 | Kelli Henning, 323 Highway 64 E, Alma, AR 72921-3318 Ph: (479) 632-9080 |
News Archive
Around a quarter of all heart attacks, strokes, and operations to open blocked arteries could be avoided in people with chronic kidney disease by using the combination of ezetimibe and simvastatin to lower blood cholesterol levels. That's the conclusion from the world's largest ever randomized trial in kidney disease.
Research conducted by scientists at the National Institutes of Health in the USA shows that Nsp15 targets uridines (U). Following detection of U, Nsp15 can then further cleave a broad spectrum of RNA substrates.
St. Louis College of Pharmacy and Washington University School of Medicine in St. Louis are joining forces to find better, safer and more effective ways to use prescription medications to improve health. Researchers from the two institutions are collaborating to create the Center for Clinical Pharmacology.
Oncolytics Biotech Inc. has announced that interim results of a Phase II study of intravenous Reolysin in patients with sarcomas metastatic to the lung were presented yesterday at the American Society of Clinical Oncology (ASCO) annual meeting.
Cancer Research UK's Drug Development Office has opened the first trial of a new drug combination in patients with advanced solid tumours and in a subset of patients who have non-small cell lung cancer. This trial will combine two compounds that aim to starve the tumours while simultaneously blocking cancer cell growth.
› Verified 6 days ago
Ms. Jennifer Lynn Woodard, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 367 W Cherry St, Alma, AR 72921 Phone: 479-632-4330 Fax: 479-632-4509 | |
Dr. Rebecca Lyn Whittington, PHARM. D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 110 Fayetteville Ave, Alma, AR 72921 Phone: 479-262-2156 | |
Kraig Kannett, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 323 Highway 64 W, Alma, AR 72921 Phone: 479-632-9080 | |
Dr. Carrie Crotts Nash, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 110 Fayetteville Ave, Alma, AR 72921 Phone: 479-262-2156 Fax: 479-262-2264 | |
Dr. Madison Green, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 323 Us-64, Alma, AR 72921 Phone: 479-632-9080 | |
Paul L Winborn Sr., R.PH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 18 Hwy 162 So, Alma, AR 72921 Phone: 479-632-2248 Fax: 479-632-2386 |